SCHEMBL6169699

SCHEMBL6169699

O=C1C(c2ccc(Oc3ccccc3)cc2)NC(=S)N1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 5/20 0.48
NPSR1 Q6W5P4 2/20 0.48
ALOX12 P18054 2/20 0.48
MGLL Q99685 1/20 0.46
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NTRK1 P04629 1/20 0.42
IGF1R P08069 1/20 0.42
FGFR1 P11362 1/20 0.42
NTRK3 Q16288 1/20 0.42
NTRK2 Q16620 1/20 0.42
UBE2N P61088 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167967 0.77 ALDH1A1 (0.52) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL6626137 0.77 MAPT (0.50) GAALMNACYP1A2CYP3A4CYP2C19
SCHEMBL4439021 0.73 LMNA (0.54) LMNAALDH1A1NPSR1MGLL
SCHEMBL4439842 0.73 LMNA (0.54) LMNAALDH1A1NPSR1MGLL
SCHEMBL4437165 0.73 LMNA (0.54) LMNAALDH1A1NPSR1MGLL
SCHEMBL6169375 0.72 GAA (0.50) GAALMNACYP1A2CYP3A4CYP2C19
SCHEMBL845936 0.71 AR (0.61) GAALMNACYP1A2CYP3A4CYP2C19
SCHEMBL10785110 0.70 GAA (0.58) GAALMNACYP1A2CYP3A4CYP2C19
SCHEMBL13813275 0.70 GAA (0.58) GAALMNACYP1A2CYP3A4CYP2C19
SCHEMBL11306432 0.69 GAA (0.43) GAALMNACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed